Biogen Inc
NASDAQ: BIIB
$159.99
-$4.90 (-3.0%)
Closing Price on November 15, 2024
BIIB Articles
Biogen Idec Inc. (NASDAQ: BIIB has notified regulatory agencies of a confirmed case of progressive multifocal leukoencephalopathy (PML) in a multiple sclerosis patient treated with TYSABRI . ...
Published:
Last Updated:
Below are some of the top analyst calls we are seeing from Wall Street firms this Thursday morning: Biogen Idec (BIIB) Raised to Buy at Lazard. Cowen (COWN) Raised to Outperform at KBW. Mylan Labs...
Published:
These are some of the early bird analyst upgrades and positive calls we are seeing this Thursday morning with more than two hours to the open: Auxilium Pharma (AUXL) Started as Outperform at...
Published:
Icahn Enterprises LP (NYSE: IEP) is perhaps known more for its billionaire owner/founder Carl Icahn more than it is for its staff, team efforts, and even the enterprise’s name. Icahn’s...
Published:
Last Updated:
These are some of the key analyst downgrades and negative analyst calls we have seen early this Monday morning with over 2 hours to open: Biogen Idec (BIIB) Cut to Sell at Banc of America. Cbeyond...
Published:
Carl Icahn has evolved over the years, first rising to fame a "corporate raider", followed by an ill-fated journey into actual management at the helm of TWA and, most recently, as a kinder, gentler...
Published:
Last Updated:
Elan Corporation (ELN) Problems with one of the company’s major drugs. Falls to $9.55 from 52-week high of $37.45. Gatehouse (GHS) More poor newspaper earnings raise issue of whether company is...
Published:
Last Updated:
This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We do not want to try to sound as though this TYSABRI news is something that...
Published:
Last Updated:
Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the U.S. is expected to post $0.86 EPS on $3.23 Billion in revenues according to First...
Published:
There was interesting event in a 13D filing today right after the close, and that will be worth some news and gossip alike. An investment firm called Amalgamated Gadget LP, which is roughly a 6.6%...
Published:
Last Updated:
Carl Icahn is a billionaire financier, activist, and investor. Most think of Icahn as an activist investor that wants to get inside and drive value without having to acquire the whole company to...
Published:
Last Updated:
Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (Nasdaq:BIIB) came out this morning with some disappointing news. The biotech giants have announced that a Phase II/III study of Rituxan for lupus...
Published:
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and Rituxan. The earnings beat estimates and...
Published:
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues. Next quarter estimates are $0.86 EPS...
Published:
Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up $1.39 to $28.97,...
Published: